Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
Status:
Withdrawn
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of celecoxib may be an effective way to prevent
actinic keratoses.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of celecoxib in
preventing skin cancer in patients who have actinic keratoses.